Last reviewed · How we verify

IPV SSI — Competitive Intelligence Brief

IPV SSI (IPV SSI) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated viral vaccine Poliovirus serotypes 1, 2, and 3 Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

IPV SSI (IPV SSI) — Statens Serum Institut. IPV SSI is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
IPV SSI TARGET IPV SSI Statens Serum Institut phase 3 Inactivated viral vaccine Poliovirus serotypes 1, 2, and 3
Sabin IPV Sabin IPV Centers for Disease Control and Prevention, China marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
fIPV (0.1mL) IM fIPV (0.1mL) IM Centers for Disease Control and Prevention marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
IPV-Al IPV-Al AJ Vaccines A/S marketed Inactivated viral vaccine Poliovirus serotypes 1, 2, and 3
vaccinated with Sabin IPV vaccinated with Sabin IPV Zhejiang Provincial Center for Disease Control and Prevention marketed vaccine poliovirus serotypes 1, 2, and 3
Sabin IPV + Sabin IPV + Sabin IPV Sabin IPV + Sabin IPV + Sabin IPV Zhejiang Provincial Center for Disease Control and Prevention marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
2wIPV+1sIPV 2wIPV+1sIPV Sinovac Biotech Co., Ltd marketed Inactivated viral vaccine Poliovirus types 1, 2, and 3 antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

  1. Sinovac Biotech Co., Ltd · 9 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
  3. GlaxoSmithKline · 5 drugs in this class
  4. Valneva Austria GmbH · 4 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Centers for Disease Control and Prevention · 3 drugs in this class
  7. China National Biotec Group Company Limited · 2 drugs in this class
  8. Statens Serum Institut · 2 drugs in this class
  9. Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
  10. Crucell Holland BV · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IPV SSI — Competitive Intelligence Brief. https://druglandscape.com/ci/ipv-ssi. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: